Screening potential lncRNA biomarkers for breast cancer and colorectal cancer combining random walk and logistic matrix factorization

被引:1
作者
Li, Shijun [1 ]
Chang, Miaomiao [1 ]
Tong, Ling [1 ]
Wang, Yuehua [1 ]
Wang, Meng [1 ]
Wang, Fang [1 ]
机构
[1] Chifeng Municipal Hosp, Dept Pathol, Chifeng, Peoples R China
关键词
breast cancer; colorectal cancer; lncRNA; biomarker; lncRNA-disease association; random walk; logistic matrix factorization; LONG NONCODING RNA; FUNCTIONAL SIMILARITY; DISEASE ASSOCIATIONS; ENSEMBLE METHOD; PREDICTION; EXPRESSION; HULC;
D O I
10.3389/fgene.2022.1023615
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Breast cancer and colorectal cancer are two of the most common malignant tumors worldwide. They cause the leading causes of cancer mortality. Many researches have demonstrated that long noncoding RNAs (lncRNAs) have close linkages with the occurrence and development of the two cancers. Therefore, it is essential to design an effective way to identify potential lncRNA biomarkers for them. In this study, we developed a computational method (LDA-RWLMF) by integrating random walk with restart and Logistic Matrix Factorization to investigate the roles of lncRNA biomarkers in the prognosis and diagnosis of the two cancers. We first fuse disease semantic and Gaussian association profile similarities and lncRNA functional and Gaussian association profile similarities. Second, we design a negative selection algorithm to extract negative LncRNA-Disease Associations (LDA) based on random walk. Third, we develop a logistic matrix factorization model to predict possible LDAs. We compare our proposed LDA-RWLMF method with four classical LDA prediction methods, that is, LNCSIM1, LNCSIM2, ILNCSIM, and IDSSIM. The results from 5-fold cross validation on the MNDR dataset show that LDA-RWLMF computes the best AUC value of 0.9312, outperforming the above four LDA prediction methods. Finally, we rank all lncRNA biomarkers for the two cancers after determining the performance of LDA-RWLMF, respectively. We find that 48 and 50 lncRNAs have the highest association scores with breast cancer and colorectal cancer among all lncRNAs known to associate with them on the MNDR dataset, respectively. We predict that lncRNAs HULC and HAR1A could be separately potential biomarkers for breast cancer and colorectal cancer and need to biomedical experimental validation.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Detection and identification of potential biomarkers of breast cancer
    Fan, Yuxia
    Wang, Jiachen
    Yang, Yang
    Liu, Qiuliang
    Fan, Yingzhong
    Yu, Jiekai
    Zheng, Shu
    Li, Mengquan
    Wang, Jiaxiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) : 1243 - 1254
  • [22] Circular RNAs as Potential Biomarkers in Breast Cancer
    De Palma, Fatima Domenica Elisa
    Salvatore, Francesco
    Pol, Jonathan G.
    Kroemer, Guido
    Maiuri, Maria Chiara
    BIOMEDICINES, 2022, 10 (03)
  • [23] MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review
    Toiyama, Yuji
    Okugawa, Yoshinaga
    Fleshman, James
    Boland, C. Richard
    Goel, Ajay
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (02): : 274 - 282
  • [24] MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review
    Liu, Jianrong
    Ke, Fei
    Chen, Tingting
    Zhou, Qing
    Weng, Lingling
    Tan, Jiani
    Shen, Weixing
    Li, Liu
    Zhou, Jinyong
    Xu, Changliang
    Cheng, Haibo
    Zhou, Jinrong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (04) : 809 - 820
  • [25] Identification of key genes in colorectal cancer using random walk with restart
    Cui, Xiaofeng
    Shen, Kexin
    Xie, Zhongshi
    Liu, Tongjun
    Zhang, Haishan
    MOLECULAR MEDICINE REPORTS, 2017, 15 (02) : 867 - 872
  • [26] Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection
    Slaby, Ondrej
    NON-CODING RNAS IN COLORECTAL CANCER, 2016, 937 : 153 - 170
  • [27] Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis
    Ajithkumar, Priyadarshana
    Vasantharajan, Sai Shyam
    Pattison, Sharon
    McCall, John L.
    Rodger, Euan J.
    Chatterjee, Aniruddha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [28] Disparities in colorectal cancer screening among breast and prostate cancer survivors
    Dash, Chiranjeev
    Lu, Jiachen
    Parikh, Vicky
    Wathen, Stacey
    Shah, Samay
    Chaudhari, Ruchi Shah
    Adams-Campbell, Lucile
    CANCER MEDICINE, 2021, 10 (04): : 1448 - 1456
  • [29] Detection and identification of potential biomarkers of breast cancer
    Yuxia Fan
    Jiachen Wang
    Yang Yang
    Qiuliang Liu
    Yingzhong Fan
    Jiekai Yu
    Shu Zheng
    Mengquan Li
    Jiaxiang Wang
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1243 - 1254
  • [30] Disparities in cancer screening in individuals with a family history of breast or colorectal cancer
    Ponce, Ninez A.
    Tsui, Jennifer
    Knight, Sara J.
    Afable-Munsuz, Aimee
    Ladabaum, Uri
    Hiatt, Robert A.
    Haas, Jennifer S.
    CANCER, 2012, 118 (06) : 1656 - 1663